Papers: 29 Nov 2013 - 6 Dec 2013 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Editors' Pick Interferon Beta-1b may reverse axonal dysfunction in multiple sclerosis. Takeuchi C, Ota K, Ono Y, Iwata M Neuroradiol J. 2007 Oct 31; 20(5):531-40. Epub 2007 Oct 31. PMID: 24299942. Abstract [Clinical and electrophysiological and molecular genetic characteristics of the course of relapsing-remitting multiple sclerosis.] Delov RA, Rozhdestvenskiĭ AS, Marks EA, Smialovskiĭ VE, Khanokh EV, Kakulia AV, Sokolova EA, Agapova IO Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10):55-59. PMID: 24300807. Abstract [Clinical characteristics of multiple sclerosis in the Tomsk region.] Alifirova VM, Titova MA Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):15-17. PMID: 24300813. Abstract [The CD100 semaphorin expression on peripheral blood T-lymphocytes in patients with relapsing-remitting multiple sclerosis.] Trushnikova TN, Baĭdina TV, Danchenko II, Kuklina EM, Nekrasova IV Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):47-51. PMID: 24300815. Abstract [Relationship between biochemical parameters of cerebrospinal fluid and the course of multiple sclerosis.] Smagina IV, El'chaninova SA Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):43-46. PMID: 24300814. Abstract [Epidemiological characteristics of multiple sclerosis in the Kabardino-Balkaria Republic.] Zikhova AR, Berezgova LM, Tlapshokova LB, Boĭko AN Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):5-7. PMID: 24300811. Abstract [Prognostic factors of multiple sclerosis in children and adolescents after the first demyelinating event.] Kovtun OP, Nevmerzhitskaia KS Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):57-60. PMID: 24300817. Abstract [Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis.] Bykova OV, Nankina IA, Platonova AN, Karpacheva NG, Petrova OA, Gorina TP, Batysheva TT, Serkov SV, Kuzenkova LM Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):61-68. PMID: 24300818. Abstract [Controlled research on multiple sclerosis treated with electroacupuncture and acupoint injection]. Ding Y, Shi X Zhongguo Zhen Jiu. 2013 Sep; 33(9):793-5. PMID: 24298767. Abstract Crohn's disease: Is there a place for neurological screening? Stovicek J, Liskova P, Lisy J, Hlava S, Keil R Scand J Gastroenterol. 2013 Dec 4. PMID: 24299027. Abstract Effects of Multiple Sclerosis on Female Sexuality: A Controlled Study. Gumus H, Akpinar Z, Yilmaz H J Sex Med. 2013 Dec 2. PMID: 24299569. Abstract [Pregnancy and delivery in women with multiple sclerosis: a retrospective analysis.] Popova EV, Kukel' TM, Muravin AI, Boĭko AN, Murashko AV, Gusev EI Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):52-56. PMID: 24300816. Abstract [Clinical epidemiology of multiple sclerosis in Moscow. Discriptive epidemiology in population of one region of Moscow.] Boĭko AN, Kukel' TM, Lysenko MA, Vdovichenko TV, Gusev EI Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):8-14. PMID: 24300812. Abstract [Brain metabolism in multiple sclerosis: effects of neurotrophic therapy.] Pukhov RV, Bisaga GN, Trufanov AG, Efimtsev IA, Fokin VA Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):97-104. PMID: 24300822. Abstract Guideline for the diagnosis and management of multiple sclerosis: A Southern African perspective. Giampaolo D, Bhigjee A, Retief C, Isaacs M, Britz M, Opperman D, Govender R, Van Rensburg M S Afr Med J. 2013 Sep; 103(9):670-91. PMID: 24300689. Abstract Depression as a predictor of occupational transition in a multiple sclerosis cohort. Patten SB, Williams JVA, Lavorato DH, Koch M, Metz LM Funct Neurol. 2013 Dec 3:1-6. PMID: 24300037. Abstract [Quality of life of patients receiving long-term treatment with first-line disease-modifying drugs: results of a Russian multicenter study using MusiQoL.] Boĭko OV, Popova EV, Boĭko AN Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):86-92. PMID: 24300820. Abstract [The first experience of the use the Russian Β-interferon-1b biosimilar (infibeta) in the daily practice of the Moscow Center of Multiple Sclerosis.] Popova EV, Boĭko AN, Davydovskaia MV, Demina TL, Kukel' TM, Lashch IN, Popova NF, Khachanova NV, Shchur SG, Gusev EI Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):93-96. PMID: 24300821. Abstract [Local reactions to disease-modifying drugs: pathogenesis and relationship to clinical effectiveness.] Kasatkin DS, Spirin NN Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):82-85. PMID: 24300819. Abstract The risk of Bipolar Disorders in Multiple Sclerosis. Carta MG, Moro MF, Lorefice L, Trincas G, Cocco E, Giudice DE, Fenu G, Colom F, Marrosu MG J Affect Disord. 2013 Nov 19. PMID: 24295600. Abstract Methods for the detection of peptidylarginine deiminase activity and protein citrullination. Hensen SMM, Pruijn GJM Mol Cell Proteomics. 2013 Dec 2. PMID: 24298040. Abstract Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis. Nisticò R, Mori F, Feligioni M, Nicoletti F, Centonze D Philos Trans R Soc Lond B Biol Sci. 2014; 369(1633):20130162. PMID: 24298163. Abstract A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility. Song G G, Lee Y H Immunol Invest. 2013 Dec 2. PMID: 24295368. Abstract Ultrasonographic diagnosis of demyelinating neuropathy. Sugimoto T, Ochi K, Matsumoto M Rinsho Shinkeigaku. 2013; 53(11):1208-11. PMID: 24291932. Abstract Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials. Kitley J, Leite IM, Elsone L, Jacob A, Palace J J Neurol Neurosurg Psychiatry. 2013 Nov 29. PMID: 24292996. Abstract Immune surveillance and response to JC virus infection and PML. Beltrami S, Gordon J J Neurovirol. 2013 Dec 3. Epub 2013 Dec 03. PMID: 24297501. Abstract Axonal excitability in X-linked dominant Charcot Marie Tooth disease. Liang C, Howells J, Kennerson M, Nicholson GA, Burke D, Ng K Clin Neurophysiol. 2013 Nov 13. PMID: 24290847. Abstract Long-term effects of dalfampridine in patients with multiple sclerosis. Ruck T, Bittner S, Simon OJ, Göbel K, Wiendl H, Schilling M, Meuth SG J Neurol Sci. 2013 Nov 16. PMID: 24290498. Abstract Neuromyelitis Optica Preceded by HyperCKemia and a Possible Association with Coxsackie Virus Group A10 Infection. Okada H, Wada M, Sato H, Yamaguchi Y, Tanji H, Kurokawa K, Kawanami T, Takahashi T, Kato T Intern Med. 2013; 52(23):2665-8. PMID: 24292760. Abstract Immunology for understanding the pathogenesis of multiple sclerosis. Matsui M Rinsho Shinkeigaku. 2013; 53(11):898-901. PMID: 24291827. Abstract Cutting-edge of advanced MRI for demyelinating diseases. Harada M Rinsho Shinkeigaku. 2013; 53(11):1094-6. PMID: 24291889. Abstract Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes. De Stefano N, Comi G, Kappos L, Freedman MS, Polman CH, Uitdehaag B M, Hennessy B, Casset-Semanaz F, Lehr L, Stubinski B, et al. J Neurol Neurosurg Psychiatry. 2013 Nov 29. PMID: 24292999. Abstract The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis. Weiland TJ, Hadgkiss EJ, Jelinek GA, Pereira NG, Marck CH, van der Meer DM J Neurol Sci. 2013 Nov 8. PMID: 24290614. Abstract Oxidative modification of blood serum proteins in multiple sclerosis after interferon or mitoxantrone treatment. Sadowska-Bartosz I, Adamczyk-Sowa M, Gajewska A, Bartosz G J Neuroimmunol. 2013 Nov 16. PMID: 24290230. Abstract Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis. Izquierdo G, O'Connor P, Montalban X, von Rosenstiel P, Cremer M, de Vera A, Sfikas N, Francis G, Radue E, Kappos L Mult Scler. 2013 Nov 30. PMID: 24293455. Abstract A case of fulminant neuromyelitis optica presenting with destructive lesions in whole-brain. Sugiyama A, Ito S, Hirano S, Mori M, Kuwabara S Clin Neurol Neurosurg. 2013 Nov 14. PMID: 24289957. Abstract Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody. Samukawa M, Hamada Y, Kuwahara M, Takada K, Hirano M, Mitsui Y, Sonoo M, Kusunoki S, the Japanese GBS Study Group J Neurol Sci. 2013 Nov 19. PMID: 24289889. Abstract Risk evaluation and monitoring in multiple sclerosis therapeutics. Clanet MC, Wolinsky JS, Ashton RJ, Hartung H-P, Reingold SC Mult Scler. 2013 Nov 30. PMID: 24293456. Abstract The coexistence of well- and ill-being in persons with multiple sclerosis, their caregivers and health professionals. Bassi M, Falautano M, Cilia S, Goretti B, Grobberio M, Pattini M, Pietrolongo E, Viterbo R G, Amato M P, Benin M, et al. J Neurol Sci. 2013 Nov 19. PMID: 24289888. Abstract [Neurological manifestations of Behçet's disease.] Noel N, Drier A, Wechsler B, Piette J-C, Depaz R, Dormont D, Cacoub P, Saadoun D Rev Med Interne. 2013 Nov 26. PMID: 24290030. Abstract Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study. Conforti R, Cirillo M, Saturnino P P, Gallo A, Sacco R, Negro A, Paccone A, Caiazzo G, Bisecco A, Bonavita S, et al. Radiol Med. 2013 Dec 3. Epub 2013 Dec 03. PMID: 24297592. Abstract FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease. Di Pardo A, Amico E, Favellato M, Castrataro R, Fucile S, Squitieri F, Maglione V Hum Mol Genet. 2013 Dec 18. Epub 2013 Dec 02. PMID: 24301680. Abstract Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. Najjar S, Pearlman DM, Devinsky O, Najjar A, Zagzag D J Neuroinflammation. 2013; 10(1):142. Epub 2013 Dec 01. PMID: 24289502. Abstract Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I). Zettl UK, Henze T, Essner U, Flachenecker P Eur J Health Econ. 2013 Dec 1. Epub 2013 Dec 01. PMID: 24292503. Abstract Neuroimaging of dementia. Bertelson JA, Ajtai B Neurol Clin. 2014 Feb; 32(1):59-93. PMID: 24287385. Abstract Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis. Al-Izki S, Pryce G, Hankey DJR, Lidster K, von Kutzleben SM, Browne L, Clutterbuck L, Posada C, Edith Chan AW, Amor S, et al. Brain. 2013 Nov 27. PMID: 24287115. Abstract Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions. Wrzos C, Winkler A, Metz I, Kayser DM, Thal DR, Wegner C, Brück W, Nessler S, Bennett JL, Stadelmann C Acta Neuropathol. 2013 Nov 30. Epub 2013 Nov 30. PMID: 24292009. Abstract Does long-term partial sodium channel blockade alter disease progression in MS? Evidence from a retrospective study. Counihan TJ, Duignan JA, Gormley G, Saidha S, Dooley C, Newell J Ir J Med Sci. 2013 Nov 28. Epub 2013 Nov 28. PMID: 24287594. Abstract Protocol to isolate a large amount of functional oligodendrocyte precursor cells from the cerebral cortex of adult mice and humans. Medina-Rodríguez E M, Arenzana F J, Bribián A, de Castro F PLoS One. 2013; 8(11):e81620. Epub 2013 Nov 26. PMID: 24303061. Abstract Erratum: Genomic analysis of ERVWE2 locus in patients with Multiple sclerosis: absence of genetic association but potential role of Human Endogenous retrovirus type W elements in molecular mimicry with myelin antigen. Romano C M Front Microbiol. 2013; 4:345. Epub 2013 Nov 18. PMID: 24302922. Abstract The Afferent Visual Pathway: Designing a Structural-Functional Paradigm of Multiple Sclerosis. Costello F ISRN Neurol. 2013; 2013:134858. Epub 2013 Nov 06. PMID: 24288622. Abstract Pediatric Multiple Sclerosis: Current Concepts and Consensus Definitions. Pena JA, Lotze TE Autoimmune Dis. 2013; 2013:673947. Epub 2013 Nov 02. PMID: 24294520. Abstract The Contribution of Resting State Networks to the Study of Cortical Reorganization in MS. Sacco R, Bonavita S, Esposito F, Tedeschi G, Gallo A Mult Scler Int. 2013; 2013:857807. Epub 2013 Oct 31. PMID: 24288613. Abstract Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination. Syed YA, Baer A, Hofer MP, González GA, Rundle J, Myrta S, Huang JK, Zhao C, Rossner MJ, Trotter MWB, et al. EMBO Mol Med. 2013 Dec; 5(12):1918-34. Epub 2013 Oct 21. PMID: 24293318. Abstract Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy. Liao C, Hsu J, Kim Y, Hu D-Q, Xu D, Zhang J, Pashine A, Menke J, Whittard T, Romero N, et al. Arthritis Res Ther. 2013; 15(5):R146. Epub 2013 Oct 04. PMID: 24286216. Abstract Catechol-O-Methyltransferase Val158Met Polymorphism (rs4680) Is Associated With Pain in Multiple Sclerosis. Fernández-de-Las-Peñas C, Ambite-Quesada S, Ortíz-Gutiérrez R, Ortega-Santiago R, Gil-Crujera A, Caminero AB J Pain. 2013 Dec; 14(12):1719-23. Epub 2013 Sep 28. PMID: 24290452. Abstract [Autonomic nervous system alteration in multiple sclerosis patients with urinary symptoms. Clinical, urodynamic and cardiovascular study]. Amarenco G, Raibaut P, Hubeaux K, Jousse M, Sheikh Ismaël S, Lapeyre E Prog Urol. 2013 Dec; 23(17):1505-10. Epub 2013 Aug 01. PMID: 24286553. Abstract Clinical Outcome of 50 Progressive Multiple Sclerosis Patients Treated with Cellular Therapy in Iraq. Hammadi A MA, Marino A, Farhan S Int J Stem Cells. 2011 Nov; 4(2):113-115. PMID: 24298343. Abstract Extremely low-frequency pulsed magnetic fields and multiple sclerosis: effects on neurotransmission alone or also on immunomodulation? Building a working hypothesis. Bistolfi F Neuroradiol J. 2007 Dec 31; 20(6):676-93. Epub 2007 Dec 31. PMID: 24300003. Abstract Behçet's Disease Presenting with Acute Transverse Myelitis: MRI Findings and Review of the Nosology. A Case Report. Sanal HT, Bulakbasi N, Kocaoglu M, Tayfun C Neuroradiol J. 2007 Apr 30; 20(2):233-6. Epub 2007 Apr 30. PMID: 24299651. Abstract Cytokines and soluble IL-4 in patients with acute optic neuritis and multiple sclerosis. Sellebjerg F, Bendtzen K, Christiansen M, Frederiksen J Eur J Neurol. 1997 Jan; 4(1):59-67. PMID: 24283823. Abstract Diagnostic problems in "clinically definite" multiple sclerosis patients with normal CSF and multiple MRI abnormalities. Fieschi C, Gasperini C, Ristori G, Bastianello S, Girmenia F, Leuzzi V, Buttinelli C, Pozzilli C, Rasura M Eur J Neurol. 1994 Nov; 1(2):127-33. PMID: 24283480. Abstract Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases. Paemen L, Olsson T, Söderström M, van Damme J, Opdenakker G Eur J Neurol. 1994 Sep; 1(1):55-63. PMID: 24283430. Abstract Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis. Olsson T Eur J Neurol. 1994 Sep; 1(1):7-19. PMID: 24283424. Abstract
Editors' Pick Interferon Beta-1b may reverse axonal dysfunction in multiple sclerosis. Takeuchi C, Ota K, Ono Y, Iwata M Neuroradiol J. 2007 Oct 31; 20(5):531-40. Epub 2007 Oct 31. PMID: 24299942. Abstract
[Clinical and electrophysiological and molecular genetic characteristics of the course of relapsing-remitting multiple sclerosis.] Delov RA, Rozhdestvenskiĭ AS, Marks EA, Smialovskiĭ VE, Khanokh EV, Kakulia AV, Sokolova EA, Agapova IO Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10):55-59. PMID: 24300807. Abstract
[Clinical characteristics of multiple sclerosis in the Tomsk region.] Alifirova VM, Titova MA Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):15-17. PMID: 24300813. Abstract
[The CD100 semaphorin expression on peripheral blood T-lymphocytes in patients with relapsing-remitting multiple sclerosis.] Trushnikova TN, Baĭdina TV, Danchenko II, Kuklina EM, Nekrasova IV Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):47-51. PMID: 24300815. Abstract
[Relationship between biochemical parameters of cerebrospinal fluid and the course of multiple sclerosis.] Smagina IV, El'chaninova SA Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):43-46. PMID: 24300814. Abstract
[Epidemiological characteristics of multiple sclerosis in the Kabardino-Balkaria Republic.] Zikhova AR, Berezgova LM, Tlapshokova LB, Boĭko AN Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):5-7. PMID: 24300811. Abstract
[Prognostic factors of multiple sclerosis in children and adolescents after the first demyelinating event.] Kovtun OP, Nevmerzhitskaia KS Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):57-60. PMID: 24300817. Abstract
[Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis.] Bykova OV, Nankina IA, Platonova AN, Karpacheva NG, Petrova OA, Gorina TP, Batysheva TT, Serkov SV, Kuzenkova LM Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):61-68. PMID: 24300818. Abstract
[Controlled research on multiple sclerosis treated with electroacupuncture and acupoint injection]. Ding Y, Shi X Zhongguo Zhen Jiu. 2013 Sep; 33(9):793-5. PMID: 24298767. Abstract
Crohn's disease: Is there a place for neurological screening? Stovicek J, Liskova P, Lisy J, Hlava S, Keil R Scand J Gastroenterol. 2013 Dec 4. PMID: 24299027. Abstract
Effects of Multiple Sclerosis on Female Sexuality: A Controlled Study. Gumus H, Akpinar Z, Yilmaz H J Sex Med. 2013 Dec 2. PMID: 24299569. Abstract
[Pregnancy and delivery in women with multiple sclerosis: a retrospective analysis.] Popova EV, Kukel' TM, Muravin AI, Boĭko AN, Murashko AV, Gusev EI Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):52-56. PMID: 24300816. Abstract
[Clinical epidemiology of multiple sclerosis in Moscow. Discriptive epidemiology in population of one region of Moscow.] Boĭko AN, Kukel' TM, Lysenko MA, Vdovichenko TV, Gusev EI Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):8-14. PMID: 24300812. Abstract
[Brain metabolism in multiple sclerosis: effects of neurotrophic therapy.] Pukhov RV, Bisaga GN, Trufanov AG, Efimtsev IA, Fokin VA Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):97-104. PMID: 24300822. Abstract
Guideline for the diagnosis and management of multiple sclerosis: A Southern African perspective. Giampaolo D, Bhigjee A, Retief C, Isaacs M, Britz M, Opperman D, Govender R, Van Rensburg M S Afr Med J. 2013 Sep; 103(9):670-91. PMID: 24300689. Abstract
Depression as a predictor of occupational transition in a multiple sclerosis cohort. Patten SB, Williams JVA, Lavorato DH, Koch M, Metz LM Funct Neurol. 2013 Dec 3:1-6. PMID: 24300037. Abstract
[Quality of life of patients receiving long-term treatment with first-line disease-modifying drugs: results of a Russian multicenter study using MusiQoL.] Boĭko OV, Popova EV, Boĭko AN Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):86-92. PMID: 24300820. Abstract
[The first experience of the use the Russian Β-interferon-1b biosimilar (infibeta) in the daily practice of the Moscow Center of Multiple Sclerosis.] Popova EV, Boĭko AN, Davydovskaia MV, Demina TL, Kukel' TM, Lashch IN, Popova NF, Khachanova NV, Shchur SG, Gusev EI Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):93-96. PMID: 24300821. Abstract
[Local reactions to disease-modifying drugs: pathogenesis and relationship to clinical effectiveness.] Kasatkin DS, Spirin NN Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113(10 vypusk 2 Rasseiannyi skleroz):82-85. PMID: 24300819. Abstract
The risk of Bipolar Disorders in Multiple Sclerosis. Carta MG, Moro MF, Lorefice L, Trincas G, Cocco E, Giudice DE, Fenu G, Colom F, Marrosu MG J Affect Disord. 2013 Nov 19. PMID: 24295600. Abstract
Methods for the detection of peptidylarginine deiminase activity and protein citrullination. Hensen SMM, Pruijn GJM Mol Cell Proteomics. 2013 Dec 2. PMID: 24298040. Abstract
Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis. Nisticò R, Mori F, Feligioni M, Nicoletti F, Centonze D Philos Trans R Soc Lond B Biol Sci. 2014; 369(1633):20130162. PMID: 24298163. Abstract
A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility. Song G G, Lee Y H Immunol Invest. 2013 Dec 2. PMID: 24295368. Abstract
Ultrasonographic diagnosis of demyelinating neuropathy. Sugimoto T, Ochi K, Matsumoto M Rinsho Shinkeigaku. 2013; 53(11):1208-11. PMID: 24291932. Abstract
Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials. Kitley J, Leite IM, Elsone L, Jacob A, Palace J J Neurol Neurosurg Psychiatry. 2013 Nov 29. PMID: 24292996. Abstract
Immune surveillance and response to JC virus infection and PML. Beltrami S, Gordon J J Neurovirol. 2013 Dec 3. Epub 2013 Dec 03. PMID: 24297501. Abstract
Axonal excitability in X-linked dominant Charcot Marie Tooth disease. Liang C, Howells J, Kennerson M, Nicholson GA, Burke D, Ng K Clin Neurophysiol. 2013 Nov 13. PMID: 24290847. Abstract
Long-term effects of dalfampridine in patients with multiple sclerosis. Ruck T, Bittner S, Simon OJ, Göbel K, Wiendl H, Schilling M, Meuth SG J Neurol Sci. 2013 Nov 16. PMID: 24290498. Abstract
Neuromyelitis Optica Preceded by HyperCKemia and a Possible Association with Coxsackie Virus Group A10 Infection. Okada H, Wada M, Sato H, Yamaguchi Y, Tanji H, Kurokawa K, Kawanami T, Takahashi T, Kato T Intern Med. 2013; 52(23):2665-8. PMID: 24292760. Abstract
Immunology for understanding the pathogenesis of multiple sclerosis. Matsui M Rinsho Shinkeigaku. 2013; 53(11):898-901. PMID: 24291827. Abstract
Cutting-edge of advanced MRI for demyelinating diseases. Harada M Rinsho Shinkeigaku. 2013; 53(11):1094-6. PMID: 24291889. Abstract
Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes. De Stefano N, Comi G, Kappos L, Freedman MS, Polman CH, Uitdehaag B M, Hennessy B, Casset-Semanaz F, Lehr L, Stubinski B, et al. J Neurol Neurosurg Psychiatry. 2013 Nov 29. PMID: 24292999. Abstract
The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis. Weiland TJ, Hadgkiss EJ, Jelinek GA, Pereira NG, Marck CH, van der Meer DM J Neurol Sci. 2013 Nov 8. PMID: 24290614. Abstract
Oxidative modification of blood serum proteins in multiple sclerosis after interferon or mitoxantrone treatment. Sadowska-Bartosz I, Adamczyk-Sowa M, Gajewska A, Bartosz G J Neuroimmunol. 2013 Nov 16. PMID: 24290230. Abstract
Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis. Izquierdo G, O'Connor P, Montalban X, von Rosenstiel P, Cremer M, de Vera A, Sfikas N, Francis G, Radue E, Kappos L Mult Scler. 2013 Nov 30. PMID: 24293455. Abstract
A case of fulminant neuromyelitis optica presenting with destructive lesions in whole-brain. Sugiyama A, Ito S, Hirano S, Mori M, Kuwabara S Clin Neurol Neurosurg. 2013 Nov 14. PMID: 24289957. Abstract
Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody. Samukawa M, Hamada Y, Kuwahara M, Takada K, Hirano M, Mitsui Y, Sonoo M, Kusunoki S, the Japanese GBS Study Group J Neurol Sci. 2013 Nov 19. PMID: 24289889. Abstract
Risk evaluation and monitoring in multiple sclerosis therapeutics. Clanet MC, Wolinsky JS, Ashton RJ, Hartung H-P, Reingold SC Mult Scler. 2013 Nov 30. PMID: 24293456. Abstract
The coexistence of well- and ill-being in persons with multiple sclerosis, their caregivers and health professionals. Bassi M, Falautano M, Cilia S, Goretti B, Grobberio M, Pattini M, Pietrolongo E, Viterbo R G, Amato M P, Benin M, et al. J Neurol Sci. 2013 Nov 19. PMID: 24289888. Abstract
[Neurological manifestations of Behçet's disease.] Noel N, Drier A, Wechsler B, Piette J-C, Depaz R, Dormont D, Cacoub P, Saadoun D Rev Med Interne. 2013 Nov 26. PMID: 24290030. Abstract
Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study. Conforti R, Cirillo M, Saturnino P P, Gallo A, Sacco R, Negro A, Paccone A, Caiazzo G, Bisecco A, Bonavita S, et al. Radiol Med. 2013 Dec 3. Epub 2013 Dec 03. PMID: 24297592. Abstract
FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease. Di Pardo A, Amico E, Favellato M, Castrataro R, Fucile S, Squitieri F, Maglione V Hum Mol Genet. 2013 Dec 18. Epub 2013 Dec 02. PMID: 24301680. Abstract
Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. Najjar S, Pearlman DM, Devinsky O, Najjar A, Zagzag D J Neuroinflammation. 2013; 10(1):142. Epub 2013 Dec 01. PMID: 24289502. Abstract
Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I). Zettl UK, Henze T, Essner U, Flachenecker P Eur J Health Econ. 2013 Dec 1. Epub 2013 Dec 01. PMID: 24292503. Abstract
Neuroimaging of dementia. Bertelson JA, Ajtai B Neurol Clin. 2014 Feb; 32(1):59-93. PMID: 24287385. Abstract
Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis. Al-Izki S, Pryce G, Hankey DJR, Lidster K, von Kutzleben SM, Browne L, Clutterbuck L, Posada C, Edith Chan AW, Amor S, et al. Brain. 2013 Nov 27. PMID: 24287115. Abstract
Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions. Wrzos C, Winkler A, Metz I, Kayser DM, Thal DR, Wegner C, Brück W, Nessler S, Bennett JL, Stadelmann C Acta Neuropathol. 2013 Nov 30. Epub 2013 Nov 30. PMID: 24292009. Abstract
Does long-term partial sodium channel blockade alter disease progression in MS? Evidence from a retrospective study. Counihan TJ, Duignan JA, Gormley G, Saidha S, Dooley C, Newell J Ir J Med Sci. 2013 Nov 28. Epub 2013 Nov 28. PMID: 24287594. Abstract
Protocol to isolate a large amount of functional oligodendrocyte precursor cells from the cerebral cortex of adult mice and humans. Medina-Rodríguez E M, Arenzana F J, Bribián A, de Castro F PLoS One. 2013; 8(11):e81620. Epub 2013 Nov 26. PMID: 24303061. Abstract
Erratum: Genomic analysis of ERVWE2 locus in patients with Multiple sclerosis: absence of genetic association but potential role of Human Endogenous retrovirus type W elements in molecular mimicry with myelin antigen. Romano C M Front Microbiol. 2013; 4:345. Epub 2013 Nov 18. PMID: 24302922. Abstract
The Afferent Visual Pathway: Designing a Structural-Functional Paradigm of Multiple Sclerosis. Costello F ISRN Neurol. 2013; 2013:134858. Epub 2013 Nov 06. PMID: 24288622. Abstract
Pediatric Multiple Sclerosis: Current Concepts and Consensus Definitions. Pena JA, Lotze TE Autoimmune Dis. 2013; 2013:673947. Epub 2013 Nov 02. PMID: 24294520. Abstract
The Contribution of Resting State Networks to the Study of Cortical Reorganization in MS. Sacco R, Bonavita S, Esposito F, Tedeschi G, Gallo A Mult Scler Int. 2013; 2013:857807. Epub 2013 Oct 31. PMID: 24288613. Abstract
Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination. Syed YA, Baer A, Hofer MP, González GA, Rundle J, Myrta S, Huang JK, Zhao C, Rossner MJ, Trotter MWB, et al. EMBO Mol Med. 2013 Dec; 5(12):1918-34. Epub 2013 Oct 21. PMID: 24293318. Abstract
Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy. Liao C, Hsu J, Kim Y, Hu D-Q, Xu D, Zhang J, Pashine A, Menke J, Whittard T, Romero N, et al. Arthritis Res Ther. 2013; 15(5):R146. Epub 2013 Oct 04. PMID: 24286216. Abstract
Catechol-O-Methyltransferase Val158Met Polymorphism (rs4680) Is Associated With Pain in Multiple Sclerosis. Fernández-de-Las-Peñas C, Ambite-Quesada S, Ortíz-Gutiérrez R, Ortega-Santiago R, Gil-Crujera A, Caminero AB J Pain. 2013 Dec; 14(12):1719-23. Epub 2013 Sep 28. PMID: 24290452. Abstract
[Autonomic nervous system alteration in multiple sclerosis patients with urinary symptoms. Clinical, urodynamic and cardiovascular study]. Amarenco G, Raibaut P, Hubeaux K, Jousse M, Sheikh Ismaël S, Lapeyre E Prog Urol. 2013 Dec; 23(17):1505-10. Epub 2013 Aug 01. PMID: 24286553. Abstract
Clinical Outcome of 50 Progressive Multiple Sclerosis Patients Treated with Cellular Therapy in Iraq. Hammadi A MA, Marino A, Farhan S Int J Stem Cells. 2011 Nov; 4(2):113-115. PMID: 24298343. Abstract
Extremely low-frequency pulsed magnetic fields and multiple sclerosis: effects on neurotransmission alone or also on immunomodulation? Building a working hypothesis. Bistolfi F Neuroradiol J. 2007 Dec 31; 20(6):676-93. Epub 2007 Dec 31. PMID: 24300003. Abstract
Behçet's Disease Presenting with Acute Transverse Myelitis: MRI Findings and Review of the Nosology. A Case Report. Sanal HT, Bulakbasi N, Kocaoglu M, Tayfun C Neuroradiol J. 2007 Apr 30; 20(2):233-6. Epub 2007 Apr 30. PMID: 24299651. Abstract
Cytokines and soluble IL-4 in patients with acute optic neuritis and multiple sclerosis. Sellebjerg F, Bendtzen K, Christiansen M, Frederiksen J Eur J Neurol. 1997 Jan; 4(1):59-67. PMID: 24283823. Abstract
Diagnostic problems in "clinically definite" multiple sclerosis patients with normal CSF and multiple MRI abnormalities. Fieschi C, Gasperini C, Ristori G, Bastianello S, Girmenia F, Leuzzi V, Buttinelli C, Pozzilli C, Rasura M Eur J Neurol. 1994 Nov; 1(2):127-33. PMID: 24283480. Abstract
Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases. Paemen L, Olsson T, Söderström M, van Damme J, Opdenakker G Eur J Neurol. 1994 Sep; 1(1):55-63. PMID: 24283430. Abstract
Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis. Olsson T Eur J Neurol. 1994 Sep; 1(1):7-19. PMID: 24283424. Abstract